EWHealthcareLarge-Cap

Edwards Lifesciences Corp Insider Trading Activity

Every SEC Form 4 insider transaction reported for Edwards Lifesciences Corp (EW), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are EW insiders buying or selling?

Edwards Lifesciences Corp insiders reported 2 open-market buys ($218.1K) and 522 sells ($698.9M) across 524 Form 4 filings — a net selling position of $698.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 31, 2026)

Total Form 4 filings
524
SEC EDGAR
Insider filers
21
Insider buys (2)
$218.1K
Insider sells (522)
$698.9M

Insider sentiment

Net selling

Net insider flow of $698.7M in net selling.

Recent EW insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 31, 2026Andrew M. DahlSVP, Corporate ControllerSale544$91.06$49.5K
Aug 28, 2026Annette BrulsCVP, EMEACLASale2.6K$89.98$237.9K
Aug 26, 2026Daveen ChopraCVP, TMTT, Surgical & IHFMSale31.8K$91.02$2.9M
Aug 26, 2026Wayne MarkowitzCVP, JAPACSale1.2K$91.47$113.4K
Aug 11, 2026Daniel J. LippisCVP, TAVRSale619$92.03$57.0K
Jul 30, 2026Wayne MarkowitzCVP, JAPACSale146.31$86.03$12.6K
Jul 28, 2026Wayne MarkowitzCVP, JAPACSale9.6K$85.06$819.0K
Jul 27, 2026Bernard J ZovighianCEOSale2.9K$83.93$245.1K
Jul 10, 2026Daniel J. LippisCVP, TAVRSale619$91.70$56.8K
Jul 1, 2026Daniel J. LippisCVP, TAVRSale619$91.40$56.6K
Jun 18, 2026Bernard J ZovighianCEOSale523$87.92$46.0K
May 29, 2026Andrew M. DahlSVP, Corporate ControllerSale567.53$86.08$48.9K
May 27, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale23.1K$86.42$2.0M
May 22, 2026Daveen ChopraCVP, TMTT & SurgicalSale1.5K$84.60$126.9K
May 18, 2026Daniel J. LippisCVP, TAVRSale620$81.14$50.3K
May 18, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale18.0K$81.96$1.5M
May 12, 2026Bernard J ZovighianCEOSale36.4K$77.93$2.8M
May 12, 2026Wayne MarkowitzCVP, JAPACSale593$79.73$47.3K
May 4, 2026Daniel J. LippisCVP, TAVRSale2.0K$83.49$170.2K
Apr 9, 2026Scott B. UllemCVP, Chief Financial OfficerSale13.0K$80.04$1.0M
Apr 7, 2026Daniel J. LippisCVP, TAVRSale1.0K$80.98$82.5K
Apr 2, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale22.7K$80.16$1.8M
Mar 11, 2026Scott B. UllemCVP, Chief Financial OfficerSale13.0K$84.92$1.1M
Mar 11, 2026Daniel J. LippisCVP, TAVRSale1.0K$85.38$87.0K
Mar 2, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale11.3K$85.93$974.4K

Showing the 25 most recent of 524 Form 4 filings for Edwards Lifesciences Corp.

Most active EW insiders

  • Donald E Bobo JR109 filings
  • Michael A Mussallem77 filings
  • Larry L Wood68 filings
  • Huimin Wang55 filings
  • Catherine M. Szyman53 filings

Ask anything about EW insider activity

Use Trabud's AI agent to query Edwards Lifesciences Corp's Form 4 history in plain English — "Show me EW CEO purchases this year" or compare it against any other ticker.

Open the AI agent

EW insider trading FAQ

Are Edwards Lifesciences Corp insiders buying or selling?

Across 524 SEC Form 4 filings, Edwards Lifesciences Corp (EW) insiders reported 2 open-market purchases totaling $218.1K and 522 sales totaling $698.9M. That is a net selling position of $698.7M.

How many insiders trade EW stock?

21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Edwards Lifesciences Corp. The most recent filing was accepted on Aug 31, 2026.

Where does Trabud get EW insider trading data?

All EW insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content